Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
- 1 May 1989
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 16 (5), 261-282
- https://doi.org/10.2165/00003088-198916050-00001
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- RoxithromycinDrugs, 1989
- Does Serum Protein Binding Inhibit Tissue Penetration of Antibiotics?Clinical Infectious Diseases, 1987
- Antimicrobial chemotherapy of chlamydial infection: Where next?European Journal of Clinical Microbiology & Infectious Diseases, 1986
- In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycinJournal of Antimicrobial Chemotherapy, 1986
- The Excretion of Rosaramicin in Breast MilkThe Journal of Clinical Pharmacology, 1985
- Bioinequivalence of Erythromycin Ethylsuccinate and Enteric-Coated Erythromycin Pellets Following Multiple Oral DosesThe Journal of Clinical Pharmacology, 1985
- Penetration of erythromycin into tonsillar tissueCurrent Medical Research and Opinion, 1985
- Effect of food on absorption of erythromycin. A study of two derivatives, the stearate and the baseJournal of Antimicrobial Chemotherapy, 1979
- Bioavailability of Erythromycin Ethylsuccinate in Pediatric PatientsThe Journal of Clinical Pharmacology, 1978
- Studies on Absorption, Distribution, Metabolism and Excretion of a New Macrolide Antibiotic SF-837. I. Absorption, Metabolism and Excretion of SF-837CHEMICAL & PHARMACEUTICAL BULLETIN, 1973